Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126392631 | 12639263 | 1 | I | 20160408 | 20160803 | 20160808 | 20160808 | EXP | GB2016K3795SPO | KRKA DD NOVO MESTO | 41.00 | YR | F | N | 0.00000 | 20160804 | N | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126392631 | 12639263 | 1 | PS | LANSOPRAZOLE GENERIC (LANSOPRAZOLE) UNKNOWN | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 3 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 4 | SS | APREPITANT (APREPITANT) | APREPITANT | 1 | Oral | 0 | |||||||||||
| 126392631 | 12639263 | 5 | SS | CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE) | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 6 | SS | DEXAMETHASONE (DEXAMETHASONE) | DEXAMETHASONE | 1 | Oral | 0 | |||||||||||
| 126392631 | 12639263 | 7 | SS | DOCETAXEL (DOCETAXEL) | DOCETAXEL | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 8 | SS | DOMPERIDONE (DOMPERIDONE) | DOMPERIDONE | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 9 | SS | EPIRUBICIN (EPIRUBICIN) | EPIRUBICIN | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 10 | SS | METOCLOPRAMIDE (METOCLOPRAMIDE) | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 126392631 | 12639263 | 11 | SS | PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE) | PALONOSETRON HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126392631 | 12639263 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126392631 | 12639263 | Alopecia | |
| 126392631 | 12639263 | Application site erythema | |
| 126392631 | 12639263 | Application site pruritus | |
| 126392631 | 12639263 | Catheter site vesicles | |
| 126392631 | 12639263 | Condition aggravated | |
| 126392631 | 12639263 | Ear discomfort | |
| 126392631 | 12639263 | Epistaxis | |
| 126392631 | 12639263 | Fatigue | |
| 126392631 | 12639263 | Haemoglobin decreased | |
| 126392631 | 12639263 | Joint swelling | |
| 126392631 | 12639263 | Limb discomfort | |
| 126392631 | 12639263 | Neuropathy peripheral | |
| 126392631 | 12639263 | Oedema peripheral | |
| 126392631 | 12639263 | Pain in extremity | |
| 126392631 | 12639263 | Peripheral swelling | |
| 126392631 | 12639263 | Pyrexia | |
| 126392631 | 12639263 | Rosacea | |
| 126392631 | 12639263 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126392631 | 12639263 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126392631 | 12639263 | 2 | 20160603 | 0 | ||
| 126392631 | 12639263 | 7 | 20160602 | 0 |